A viral outbreak that began in China has infected more than 45,100 people globally. The World Health Organization has named the illness COVID-19, referring to its origin late last year and the coronavirus that causes it.
The latest figures reported by each government’s health authority as of Wednesday in Beijing:
— Mainland China: 1,113 deaths among 44,653 confirmed cases, mostly in the central province of Hubei.
— Hong Kong: 50 case s, 1 death
— Macao: 10
— Japan: 203, including 174 from a cruise ship docked in Japan
— Singapore: 50
— Thailand: 33
— South Korea: 28
— Malaysia: 18
— Taiwan: 18
— Vietnam: 15
— Australia: 14
— Germany: 14
— United States: 13. Separately, one U.S. citizen died in China
— France: 11
— United Kingdom: 8
— United Arab Emirates: 8
— Canada: 7
— Philippines: 3 cases, including 1 death
— India: 3
— Italy: 3
— Russia: 2
— Spain: 2
— Belgium: 1
— Nepal: 1
— Sri Lanka: 1
— Sweden: 1
— Cambodia: 1
— Finland: 1
CRUISE SHIP WOES
Passengers aboard a cruise ship that has been barred from docking by four governments may finally set foot on land again.
Holland America Line said the MS Westerdam will arrive Thursday morning in Sihanoukville, Cambodia. The ship has been turned away by the Philippines, Taiwan, Japan and most recently Thailand.
The Westerdam has been unwelcome because of fears that those aboard could spread the virus, though its operator said no cases of the disease have been confirmed among the more than 2,200 passengers and crew on board.
TWO RUSSIANS FLEE QUARANTINE
Two Russian women who were kept in isolation for possible inflection by the virus say they fled from their hospitals this month because of uncooperative doctors, poor conditions and fear they would become infected.
Both women said their hospital ordeals began after returning from Hainan, a tropical island in southern China popular with Russian tourists.
A Chinese drug manufacturer announced it has begun producing a drug developed by U.S. company Gilead Sciences Ltd. for possible use against the new virus.
BrightGene Bio-Medical Technology Co. said in a statement issued through the Shanghai Stock Exchange that it had successfully synthesized the active ingredients in remdesivir.
A government laboratory said last week it was applying for a patent on the drug for treatment of the virus.
Gilead said earlier it was working with U.S. and Chinese authorities to test remdesivir as a treatment for the virus. Xinhua reported last week that clinical trials were starting.